Results 31 to 40 of about 1,435,723 (230)

Acceptability of the dapivirine vaginal ring for HIV-1 prevention among women reporting engagement in transactional sex. [PDF]

AIDS Care, 2023
We assessed if acceptability of the dapivirine vaginal ring for HIV prevention differed among the subgroup of women who reported engaging in transactional sex prior to enrollment in MTN-020/ASPIRE (phase III trial in Malawi, South Africa, Uganda, and ...
Browne EN, Torjesen K, Mirembe BG, Palanee-Phillips T, Jeenarain N, Chitukuta M, Stoner MCD, Mansoor LE, Reddy K, Tauya TT, Naidoo L, Siva S, Richardson B, Dadabhai S, Seyama L, Soto-Torres L, van der Straten A, MTN-020/ASPIRE Study Team.   +17 more
europepmc   +2 more sources

Association of vaginal dysbiosis and biofilm with contraceptive vaginal ring biomass in African women. [PDF]

PLoS ONE, 2017
We investigated the presence, density and bacterial composition of contraceptive vaginal ring biomass and its association with the vaginal microbiome. Of 415 rings worn by 120 Rwandese women for three weeks, the biomass density was assessed with crystal ...
Liselotte Hardy, Vicky Jespers, Irith De Baetselier, Jozefien Buyze, Lambert Mwambarangwe, Viateur Musengamana, Janneke van de Wijgert, Tania Crucitti   +7 more
doaj   +1 more source

The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence. [PDF]

AIDS Behav, 2021
Stoner MCD, Brown ER, Palanee-Phillips T, Mansoor LE, Tembo T, Nair G, Akello C, Seyama L, Jeenarain N, Naidoo L, Mgodi N, Hunidzarira P, Chitukuta M, van der Straten A, MTN-020 ASPIRE and M-025 HOPE study teams.   +14 more
europepmc   +2 more sources

Estradiol Vaginal Ring [PDF]

Definitions, 2020
A flexible elastomer ring containing 17 beta-estradiol used for estrogen replacement. Upon vaginal insertion, estradiol vaginal ring releases a consistent low-dose of estrogen which binds to and activates nuclear receptors in estrogen-responsive tissues.
openaire   +2 more sources

A randomised trial of a contraceptive vaginal ring in women at risk of HIV infection in Rwanda: Safety of intermittent and continuous use. [PDF]

PLoS ONE, 2018
BACKGROUND:Contraceptive vaginal rings could play a role in expanding the contraceptive method mix and in preparing communities for the introduction of HIV prevention and multipurpose rings.
Evelyne Kestelyn, Stephen Agaba, Jennifer Ilo Van Nuil, Mireille Uwineza, Marie Michelle Umulisa, Lambert Mwambarangwe, Jean Claude Ndagijimana, Irith De Baetselier, Jozefien Buyze, Thérèse Delvaux, Tania Crucitti, Vicky Jespers, Janneke H H M van de Wijgert, Ring Plus Study Group   +13 more
doaj   +1 more source

Impact of the menstrual cycle and ethinyl estradiol/etonogestrel contraceptive vaginal ring on granulysin and other mucosal immune mediators

American Journal of Reproductive Immunology, 2021
Changes in sex hormones during the menstrual cycle and contraceptive vaginal ring (CVR) use influence immunity within the female genital tract, but the magnitude of these effects and their anatomical location are unclear.
S. Hughes, Urvashi Pandey, C. Johnston, J. Marrazzo, F. Hladik, E. Micks   +5 more
semanticscholar   +1 more source

An isolated vaginal metastasis from intestinal signet ring cell carcinoma: a case report and literature review

BMC Cancer, 2020
Background Isolated vaginal metastases from intestinal signet ring cell carcinoma are extremely rare. There are no reported cases in the domestic or foreign literature. The characteristics of such cases of metastasis remain relatively unknown.
Xiao Dan Zhu, Jin Wang, Qin Han You, Tian An Jiang   +3 more
doaj   +1 more source

Dose-finding study of a 90-day contraceptive vaginal ring releasing estradiol and segesterone acetate. [PDF]

, 2020
ObjectiveTo evaluate serum estradiol (E2) concentrations during use of 90-day contraceptive vaginal rings releasing E2 75, 100, or 200 mcg/day and segesterone acetate (SA) 200 mcg/day to identify a dose that avoids hypoestrogenism.Study ...
Archer, David F, Barnhart, Kurt T, Blithe, Diana L, Chen, Melissa J, Creinin, Mitchell D, Jensen, Jeffrey T, Long, Jill, Shanker, Anita, Sitruk-Ware, Regine, Thomas, Michael A, Turok, David K, Variano, Bruce, Westhoff, Carolyn L   +12 more
core   +1 more source

Assessment of risk compensation following use of the dapivirine vaginal ring in southwestern Uganda

Sexually Transmitted Infections, 2021
Objectives Participation in HIV prevention trials could trigger risk compensation among participants. We evaluated potential risk compensation following use of a vaginal ring microbicide by women in a phase III trial in southwestern Uganda.
Sylvia Kusemererwa, A. Abaasa, Anita Kabarambi, Martin Onyango, J. Mugisha   +4 more
semanticscholar   +1 more source

4109 Acceptability of a Tenofovir Disoproxil Fumarate Intravaginal Ring for Human Immunodeficiency Virus Pre-Exposure Prophylaxis Among Sexually Active Women

Journal of Clinical and Translational Science, 2020
OBJECTIVES/GOALS: Vaginal ring delivery of antiretroviral drugs may provide protection against acquisition of HIV-1 when used as pre-exposure prophylaxis.
April Dobkin, Rebecca Barnett, Jessica McWalters, Laurie L. Ray, Lilia Espinoza, Aileen P. McGinn, Jessica M. Atrio, Marla J. Keller   +7 more
doaj   +1 more source